LUC7L2

LUC7 like 2, pre-mRNA splicing factor

Basic information

Region (hg38): 7:139340359-139423457

Links

ENSG00000146963NCBI:51631OMIM:613056HGNC:21608Uniprot:Q9Y383AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the LUC7L2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the LUC7L2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
10
clinvar
10
nonsense
0
start loss
0
frameshift
0
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 11 0 0

Variants in LUC7L2

This is a list of pathogenic ClinVar variants found in the LUC7L2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-139341488-A-G Usher syndrome Likely pathogenic (Dec 31, 2022)2503066
7-139376080-G-A not specified Uncertain significance (Mar 28, 2024)3292305
7-139405200-GAATATTCAGTAGGCAGGCGAGAGGTAAGGGATCCCATCCCAGAAAGAAGAGTATATGCAAAGTAACAGAGGTAGAAAACAACAGGGTAAGTTTGGGGAAACTATAAATTATGTTGTGAGGTGGGGGAGTAGCAAGAGATGGTTTAGAAAAGTACAAAGGGCCAGATCATGGAAGAAATCGTATTTTACACTAGGAATACACCACCTCGCCAGAGGATAGAAAGTTATATTGGGCCCAGTAGTAGCCCTGACTTCATTGAGGTAAGGCAGGCAGGCTCAGAACATCCTGATGTCTCAGTAGTTCATTTGGGATACGCTCAGAAAGCATTCTTTAACCACATACTGCCTTAGATAACAAGTTTTTTCTCAGCAGTTCTGAAATACTTTGAAATTTAAAATTCATTCTCTTGTTTATTCATGATCTTCTTTTTTATTTCTTTTTAGGCAGAACGTGTTCATGAGTTAAATGAAGAAATTGGTAAATTGTTAGCCAAGGTGGAACAACTAGGAGCTGAAGGGAATGTGGAGGAATCCCAGAAAGTAATGGATGAAGTAGAGAAAGCACGGGCAAAGAAAAGAGAAGCAGAGGTAAATTCTTAATAGTAGTAGACGAATTCTGCTTAATTTGGTAAGACTACAAATAAAAAGTAGTAGATGAAACTTCAGTATCTATACTTCTCTAAGAACATGTATTTGAATGGAAATTATTGAACAGTTGTTAAAGAGAAGTTGAACTAAAAGACAAAAACAAAACAAAACTCGGAAAAAGCTGGTTGTGGTGGTGCGTGCCTTTGGTCCCAGCTATTTTGCAGGCTAAGGTGGATCGCTTGAGTCCAGTTCAAGTCCAGCCTTCTTCTTTTTGTTTTTTTGAGATGGAGTTTTGCTCTTCTTGCTCAGGCAGGAGTGCAATGGCATGATCTCAGCTCACCGCAACCTCTGCCTCCCGGGTTCAAGCGATTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGATTACAGGCCCATGCCACCACACCTGGCTAATATTTATATTTTTAGTAGAGACAGGGTTTCTCCATGTTGGTCAGGCTGGTCTTGAACACCCAACCTCAGGTGATCCACCTGCCTCGGCCTCCCAAAGTGCTAGGATTACAGGCATGAACCACTGCACCAGGGCCTTTTTTTTTTTTTTTTTTAAGACAGAGTCTTACTCTCTCTCCAAGGCTGGAGTGTAGTGGTGCGATCTCAGCTCACTGAAACCTCTGCTTCCTGGGTTCAGGCGATTCTCTTGCCTCAGCCTGCTGAGTAGCTGGGACTACAGGTGTGCACCACCATGCCCGGCTAATTTTTTGTATTTTTAGTAGAGATAGGCTTTCACCATGTTGGCCAGGCTGGTCTTGAACTCCTGACCTGGGGTGATCTGTCCACCTCAGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCCGGCCTGGCCTGTTTTTTTGTTGTTGTTGTTTTTTAAAATACTTTTGGTAAATTTGTCTTTCAGAAAATCTCTCTAAGTTGTATTTATTGATATAAAGTTGTTCATAGTGTTCTCTTTTAATATCTGTAGAATGTTTGCAATTCGTGTCTTTTCTTAATTAATCTAGCTGGTCAGTTTTATTTTGTTTTTCAAAGAACCAGTCTTCTGATTTTATTGTTTTTTTCTTGTTTTCTATTTCATTGATTTCTGTTCATGTTTATTATTTCCTTATACTCCAGTGGAGAGAGGCGCTAAGGATAGAGGATGGGGATAAAGGGAACCTATAATTTTCATAACAAAATAGCCATGCTTTTGTGGTTTTTTTTTTTTTTTTTTTTTGAGCTGGAGTCTCGCCCCAGTGAGCCACCGTGCCCAGCCACTTTTGTGTATTTTTTAGAAAACACTTTTGGTATAAGCATAGTATATTTTATTTAATTGTATGACTTTTAGTGAGATTTATATGGTCATTGTTTTTCTCACTTTTGTTTAGGAAGTTTATCGGAATTCTATGCCAGCTTCCAGTTTTCAGCAGCAGAAACTTCGAGTCTGTGAAGTCTGCTCTGCCTATTTAGGACTTCATGATAATGACAGACGACTGGCTGATCATTTTGGGGGTAAACTGCACCTGGGATTTATTGAAATAAGAGAGAAGCTTGAAGAATTAAAGGTACATTGGTAAAATATTCCTCACTTTATCCTCTTGTTCTTTTGATCTGTATCAGTTGCCTTTTTGTACAATATTCTTGACTATGATTCAGTAATATAGTATCTAATGATTAATACTAAACAGTGTAGGATTATAGATGGAAATTCAAGTTGGTTTAATGGATGCTGCCTGAGAAACAGACTTAATATTATCCTGTTATTTTGGGAGTTACCATTTTATATTAGATATGACACCGAGTTAGGGATCTTTCAAACTAGTTACTAAAAGAGTCCCATAAAACTTCATTGTTATTGTTCTTTTCAATAAGGTCAATAAGAATGTAATAATATAATATTTATAAGAAGTTTGAGAAAATGAACCCAATATTAATTTGAAATATTTTGCAATTCTTTATTAAATAGCAAGCTTGCAGAATCTCTAGTTTTATTTTATGCTCCTGCTTCCACTTCAGAAAGGACTTATGAAAAAATTTATATTTTTTTAAAAGGACAATCACTATTACTTAAATAATATAGGCTTTTGTGGGGAAGACAACACAGTTTTTACTCTTGTTGTTTAGAGGGGATAAACACAAAAAAGCATGGTGATATTTCTGAAGTGGTAAAGATGAGTGTTGGTGGATATAATCTATTTACCTTTTAATATGCTGATAGCTTTTTAAGAATTGTGGCACTGTAGTGTTTTTTCATGAATTGAGGTCTGGCTGACAGATAGGAAACATGGGATAGTCATTTTCTTTGTAACTGTTATTGTCAACTGGAATTAACTCAAGGTCCATAGCATTTAAAATAATATAGAATCAGAAAATGCCTAGGGACATCTCCATATTCTCAGGTAACAGTGGGCTCTTTTCAGTATTCTGAGTAGCTAGGGTGATCTCAAGTAATTTTTTAAAAATTTCGAAAAGAGTCACTATAGCAAATAGTTACTAGGCTCCAAGTTAAAACTCCAGTGGTTCCTACTTGGGAGTCTTTGCAGATAGACCTAGCAACAGAACTCAAGCATTTTACTCATATCTTTAAAAAGCAGCAGCATCAGGATGGTAATTGGAAGTGACCTAAATATTTCCATATTAGAAATCACAGGGCATGGGAACTTGTGATTTATAATGGTTGATGTTTTTTTAAAAAATACAAAATAATACTAGAAAACATTTAGAGGAGGAAAATCTTGTAGAAGTGACTTGGAAATGTCATTAAGAAATCATGAAAGGCTAGGCGCAGTGGCTCACGCCTGTAATCCTAGCACTTTGGGAGGCCAAGGCGGGCGGATCACAAGGTCAGGAGTTCGAGACCAGTCTGGCCAATATGGTGAAATCCTGTCTCTACTAAAAATATAAAAATTAGCTGGGTGTGGTGGCATGTGCCTGTAGTCCCAGCTACTCTGGAGACTGAGGCAGGAGAATCACTTGAACCCGGGAGGTGGAGGTTGCAGTGAGCTGAGATTGTGCCACTGCACTCCAACCTGGGCGACAGAGCGAGACTCTGTCTCAAAAAAAAAAAAAAAAAGTCATGGAGCTGGGTATGGTGGCTTATGCCTGTAATCCCAGCACTTTGGGATGCCAAGGTGGCCAGATCACTTGAGGCCAGGAGTTGGAGACCAGCCTGGGCAACATGGTGAAACCCCATCTCCACTAAAAAATATTAATAGAAAAATTAGCTGGGTGTGGTGATGCACGCCTGTAATCCCAGCTCCTCAGGTGGCTGAGGCTGGCAGGTGGAGGTTGCAGTGAGCCGAGATGGTGCTACTGCACTCCAGTCTGGGCAACAGAGTAAGACTGTCTCTAAAAAAAAAATAATAAGATCATAGGCCAGTCTCAGTGGCTCGCACCTGTTAATTCCAACACTTTGGGAGGCTGAGGTGGGAGGATCACTGGAGCCCAGGAGTTGTAGACCCATCTGGGCAACATAGCGAGATTCTGTCTCTATTTTAAAATAATTTGTTTTCACTTAAAAAAAAAAACAAAAAAAAAAACCAAGTAGAAATCATGGAGAAAGGTGAAATTTTACACATTTTCCACAAAATGGGGAAAGATTATGGAAAGAAGACTTGTAGGCCTAATGATTATTTCTGGCAGTACTTCAAATTGAATTATTAAACAGATTTTGACAGCAGTTGTACTGTATTAGAAACCAGATAATATAAAGTTTAGGATAAAGCTGTTTAAGAATGGACTCAGTAAATATTCTCCTCATTTATTACTGTTTTTAAGAGAGTCGTAGCTGAGAAGCAGGAGAAAAGAAACCAGGAACGGCTGAAACGAAGAGAAGAGAGAGAGAGAGAAGAAA-G Uncertain significance (Apr 02, 2018)560143
7-139405650-C-T not specified Uncertain significance (Apr 07, 2022)2281780
7-139405765-G-A not specified Uncertain significance (Nov 13, 2023)3121543
7-139409612-G-A not specified Uncertain significance (Apr 25, 2023)2540014
7-139417617-C-T not specified Uncertain significance (Jan 12, 2024)3121544
7-139417636-A-G not specified Uncertain significance (Mar 07, 2024)3121545
7-139417656-C-T not specified Uncertain significance (Jun 13, 2023)2513162
7-139417668-C-T not specified Uncertain significance (May 08, 2024)3292306
7-139417687-G-A not specified Uncertain significance (May 15, 2023)2509244
7-139422194-T-A not specified Uncertain significance (Jan 22, 2024)3121542
7-139422266-C-T not specified Uncertain significance (Dec 01, 2022)2321384
7-139422321-G-A not specified Uncertain significance (Sep 30, 2021)2301420

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
LUC7L2protein_codingprotein_codingENST00000354926 1083094
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.05530.9451247760151247910.0000601
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.621172290.5120.00001422560
Missense in Polyphen1568.5420.21884890
Synonymous1.215769.80.8160.00000325714
Loss of Function3.32724.80.2820.00000172287

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005940.0000594
Ashkenazi Jewish0.00009960.0000993
East Asian0.000.00
Finnish0.00004810.0000464
European (Non-Finnish)0.0001020.0000883
Middle Eastern0.000.00
South Asian0.00003780.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: May bind to RNA via its Arg/Ser-rich domain.;

Recessive Scores

pRec
0.121

Intolerance Scores

loftool
rvis_EVS
0.15
rvis_percentile_EVS
64.32

Haploinsufficiency Scores

pHI
0.445
hipred
N
hipred_score
0.407
ghis
0.559

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.998

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Luc7l2
Phenotype

Gene ontology

Biological process
mRNA splice site selection
Cellular component
U1 snRNP;nuclear speck;U2-type prespliceosome
Molecular function
RNA binding;mRNA binding;protein binding;enzyme binding